Skip to main content

Advertisement

Log in

The role of intra-articular hyaluronan (Sinovial®) in the treatment of osteoarthritis

  • Review
  • Published:
Rheumatology International Aims and scope Submit manuscript

An Erratum to this article was published on 24 April 2011

Abstract

Osteoarthritis (OA) leads to significant pain and disability. For pain relief, a tailored approach using non-pharmacological and pharmacological therapies is recommended. If adequate symptom relief is not achieved with acetaminophen, other pharmacological options include non-steroidal anti-inflammatory drugs (NSAIDs), topical analgesics, intra-articular corticosteroids and intra-articular hyaluronic acid (HA) viscosupplementation. Most of these therapies generally do not improve functional ability or quality of life or are associated with tolerability concerns. In OA patients, concentration and molecular weight (MW) of HA are reduced, diminishing elastoviscosity of the synovial fluid, joint lubrication and shock absorbancy, and possibly anti-inflammatory, analgesic and chondroprotective effects. In knee OA, viscosupplementation with 3–5 weekly intra-articular HA injections diminishes pain and improves disability, generally within 1 week and for up to 3–6 months and is well tolerated. HAs have comparable efficacy as NSAIDs, with less gastrointestinal adverse events, and compared with intra-articular corticosteroids, benefits last generally longer. High MW hylans provide comparable benefits versus HA, albeit with an increased risk of immunogenic adverse events. In mild-to-moderate hip OA, intra-articular injection of HA moderately improved pain and function, generally for up to 3 months with no serious adverse events. Efficacy in other joints is being evaluated. Viscosupplementation with intra-articular Sinovial® (other trade names: Yaral®, Intragel®) injections (an HA of low-medium MW) relieves pain and improves function in OA of the knee, and other joints including the carpometacarpal joint of the thumb and the shoulder. HA viscosupplementation, including use of Sinovial®, is a valuable treatment approach for OA patients, if other therapies are contraindicated or have failed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. National Institute for Clinical Excellence (2009) OSTEOARTHRITIS National clinical guideline for care and management in adults. Cited 4 Sept 2009. Available from: http://www.nice.org.uk/nicemedia/pdf/CG059FullGuideline.pdf

  2. European Commission (2009) Indicators for monitoring Musculoskeletal Conditions Project. Cited 3 Sept 2009. Available from: http://ec.europa.eu/health/ph_information/dissemination/diseases/musculo_en.htm

  3. World Health Organization (2003) The burden of musculoskeletal conditions at the start of the new millennium. WHO Technical Report Series 919. Cited 4 Sept 2009. Available from: http://whqlibdoc.who.int/trs/WHO_TRS_919.pdf

  4. Hochberg MC (2000) Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. Semin Arthr Rheum 30(2 Suppl 1):2–10

    Article  CAS  Google Scholar 

  5. Strauss EJ, Hart JA, Miller MD, Altman RD, Rosen JE (2009) Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions. Am J Sports Med 37(8):1636–1644

    Article  PubMed  Google Scholar 

  6. Altman RD (1990) Osteoarthritis. Differentiation from rheumatoid arthritis, causes of pain, treatment. Postgrad Med 87(3):66–72 7-8

    PubMed  CAS  Google Scholar 

  7. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P et al (2003) EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 62(12):1145–1155

    Article  PubMed  CAS  Google Scholar 

  8. Zhang W, Doherty M, Arden N, Bannwarth B, Bijlsma J, Gunther KP et al (2005) EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 64(5):669–681

    Article  PubMed  CAS  Google Scholar 

  9. Balazs EA, Denlinger JL (1993) Viscosupplementation: a new concept in the treatment of osteoarthritis. J Rheumatol Suppl 39:3–9

    PubMed  CAS  Google Scholar 

  10. Dahl LB, Dahl IM, Engstrom-Laurent A, Granath K (1985) Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 44(12):817–822

    Article  PubMed  CAS  Google Scholar 

  11. Balazs E (ed) (1982) The physical properties of synovial fluid and the specific role of hyaluronic acid

  12. Castellacci E, Polieri T (2004) Antalgic effect and clinical tolerability of hyaluronic acid in patients with degenerative diseases of knee cartilage: an outpatient treatment survey. Drugs Exp Clin Res 30(2):67–73

    PubMed  CAS  Google Scholar 

  13. Moreland LW (2003) Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthr Res Ther 5(2):54–67

    Article  CAS  Google Scholar 

  14. Vitanzo PC Jr, Sennett BJ (2006) Hyaluronans: is clinical effectiveness dependent on molecular weight? Am J Orthop 35(9):421–428

    PubMed  Google Scholar 

  15. Dixon AS, Jacoby RK, Berry H, Hamilton EB (1988) Clinical trial of intra-articular injection of sodium hyaluronate in patients with osteoarthritis of the knee. Curr Med Res Opin 11(4):205–213

    Article  PubMed  CAS  Google Scholar 

  16. Maheu E, Ayral X, Dougados M (2002) A hyaluronan preparation (500–730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 56(10):804–813

    PubMed  CAS  Google Scholar 

  17. Hamburger MI, Lakhanpal S, Mooar PA, Oster D (2003) Intra-articular hyaluronans: a review of product-specific safety profiles. Semin Arthr Rheum 32(5):296–309

    Article  CAS  Google Scholar 

  18. Brzusek D, Petron D (2008) Treating knee osteoarthritis with intra-articular hyaluronans. Curr Med Res Opin 24(12):3307–3322

    Article  PubMed  CAS  Google Scholar 

  19. Migliore A, Granata M (2008) Intra-articular use of hyaluronic acid in the treatment of osteoarthritis. Clin Interv Aging 3(2):365–369

    PubMed  CAS  Google Scholar 

  20. ACR (2000) Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthr Rheum 43(9):1905–1915

    Article  Google Scholar 

  21. Roddy E, Doherty M (2003) Guidelines for management of osteoarthritis published by the American College of Rheumatology and the European League Against Rheumatism: why are they so different? Rheum Dis Clin North Am 29(4):717–731

    Article  PubMed  Google Scholar 

  22. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G (2006) Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2:CD005321

    PubMed  Google Scholar 

  23. IBSA (2009) Sinovial®: summary of product characteristics

  24. Theiler R, Bruhlmann P (2005) Overall tolerability and analgesic activity of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Curr Med Res Opin 21(11):1727–1733

    Article  PubMed  CAS  Google Scholar 

  25. Roux C, Fontas E, Breuil V, Brocq O, Albert C, Euller-Ziegler L (2007) Injection of intra-articular sodium hyaluronidate (Sinovial) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis. A prospective evaluation of efficacy. Joint Bone Spine 74(4):368–372

    Article  PubMed  CAS  Google Scholar 

  26. Gomis A, Pawlak M, Balazs EA, Schmidt RF, Belmonte C (2004) Effects of different molecular weight elastoviscous hyaluronan solutions on articular nociceptive afferents. Arthr Rheum 50(1):314–326

    Article  CAS  Google Scholar 

  27. Weiss C, Band PA (1999) Basic principles underlying the development of viscosupplementation for the treatment of osteoarthritis. J Clin Rheumatol 3:S2–S11

    Google Scholar 

  28. Lo GH, LaValley M, McAlindon T, Felson DT (2003) Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 290(23):3115–3121

    Article  PubMed  CAS  Google Scholar 

  29. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G et al (1999) The role of elastoviscosity in the efficacy of viscosupplementation for osteoarthritis of the knee: a comparison of hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther 21(9):1549–1562

    Article  PubMed  CAS  Google Scholar 

  30. Ghosh P, Guidolin D (2002) Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthr Rheum 32(1):10–37

    Article  CAS  Google Scholar 

  31. Reichenbach S, Blank S, Rutjes AW, Shang A, King EA, Dieppe PA et al (2007) Hylan versus hyaluronic acid for osteoarthritis of the knee: a systematic review and meta-analysis. Arthr Rheum 57(8):1410–1418

    Article  Google Scholar 

  32. Onel E, Kolsun K, Kauffman JI (2008) Post-Hoc analysis of a head-to-head hyaluronic acid comparison in knee osteoarthritis using the 2004 OMERACT-OARSI responder criteria. Clin Drug Investig 28(1):37–45

    Article  PubMed  Google Scholar 

  33. Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B (2006) A prospective randomised controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 26(4):325–330

    Article  PubMed  CAS  Google Scholar 

  34. Brun P, Panfilo S, Daga Gordini D, Cortivo R, Abatangelo G (2003) The effect of hyaluronan on CD44-mediated survival of normal and hydroxyl radical-damaged chondrocytes. Osteoarthr Cartil 11(3):208–216

    Article  PubMed  CAS  Google Scholar 

  35. Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM (2006) High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthr Cartil 14(12):1237–1247

    Article  PubMed  Google Scholar 

  36. Chou CL, Li HW, Lee SH, Tsai KL, Ling HY (2008) Effect of intra-articular injection of hyaluronic acid in rheumatoid arthritis patients with knee osteoarthritis. J Chin Med Assoc 71(8):411–415

    Article  PubMed  Google Scholar 

  37. Leopold SS, Warme WJ, Pettis PD, Shott S (2002) Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment. J Bone Joint Surg Am 84-A(9):1619–1623

    PubMed  Google Scholar 

  38. Pullman-Mooar S, Mooar P, Sieck M, Clayburne G, Schumacher HR (2002) Are there distinctive inflammatory flares after hylan g-f 20 intraarticular injections? J Rheumatol 29(12):2611–2614

    PubMed  CAS  Google Scholar 

  39. Goldberg VM, Coutts RD (2004) Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment. Clin Orthop Relat Res 419:130–137

    Article  PubMed  Google Scholar 

  40. Carrabba M, Paresce E, Angelini M et al (1995) The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 15:25–31

    Google Scholar 

  41. Dougados M, Nguyen M, Listrat V, Amor B (1993) High molecular weight sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1 year placebo-controlled trial. Osteoarthr Cartil 1(2):97–103

    Article  PubMed  CAS  Google Scholar 

  42. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B et al (1997) Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthr Cartil 5(3):153–160

    Article  PubMed  CAS  Google Scholar 

  43. Novaes AC, Schaiquevich P, Nasswetter G (2005) Multicenter study of hyaluronic acid obtained by biotechnology to evaluate clinical efficacy and safety in knee osteoarthritis. Int J Clin Pharmacol Res 25(1):1–7

    PubMed  CAS  Google Scholar 

  44. Petrella RJ (2005) Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil 84(4):278–283 quiz 84, 93

    Article  PubMed  Google Scholar 

  45. Altman RD, Moskowitz R (1998) Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 25(11):2203–2212

    PubMed  CAS  Google Scholar 

  46. Jones AC, Pattrick M, Doherty S, Doherty M (1995) Intra-articular hyaluronic acid compared to intra-articular triamcinolone hexacetonide in inflammatory knee osteoarthritis. Osteoarthr Cartil 3(4):269–273

    Article  PubMed  CAS  Google Scholar 

  47. Wobig M, Dickhut A, Maier R, Vetter G (1998) Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 20(3):410–423

    Article  PubMed  CAS  Google Scholar 

  48. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade JP et al (1995) The role of viscosupplementation with hylan G-F 20 (Synvisc) in the treatment of osteoarthritis of the knee: a Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone. Osteoarthr Cartil 3(4):213–225

    Article  PubMed  CAS  Google Scholar 

  49. Dickson DJ, Hosie G, English JR et al (2001) A double-blind, placebo-controlled comparison of hylan G-F 20 against diclofenac in knee osteoarthritis. J Drug Assess 4:179–190

    Google Scholar 

  50. Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S (2003) Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am 85-A(7):1197–1203

    PubMed  Google Scholar 

  51. Karatosun V, Unver B, Gocen Z, Sen A (2005) Comparison of two hyaluronan drugs in patients with advanced osteoarthritis of the knee. A prospective, randomized, double-blind study with long term follow-up. Clin Exp Rheumatol 23(2):213–218

    PubMed  CAS  Google Scholar 

  52. Karlsson J, Sjogren LS, Lohmander LS (2002) Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology 41(11):1240–1248

    Article  PubMed  CAS  Google Scholar 

  53. Pourbagher MA, Ozalay M, Pourbagher A (2005) Accuracy and outcome of sonographically guided intra-articular sodium hyaluronate injections in patients with osteoarthritis of the hip. J Ultrasound Med 24(10):1391–1395

    PubMed  Google Scholar 

  54. Abate M, Pelotti P, De Amicis D, Di Iorio A, Galletti S, Salini V (2008) Viscosupplementation with hyaluronic acid in hip osteoarthritis (a review). Ups J Med Sci 113(3):261–277

    Article  PubMed  Google Scholar 

  55. Fernandez Lopez JC, Ruano-Ravina A (2006) Efficacy and safety of intraarticular hyaluronic acid in the treatment of hip osteoarthritis: a systematic review. Osteoarthr Cartil 14(12):1306–1311

    Article  PubMed  CAS  Google Scholar 

  56. Gaston MS, Tiemessen CH, Philips JE (2007) Intra-articular hip viscosupplementation with synthetic hyaluronic acid for osteoarthritis: efficacy, safety and relation to pre-injection radiographs. Arch Orthop Trauma Surg 127(10):899–903

    Article  PubMed  CAS  Google Scholar 

  57. Migliore A, Tormenta S, Massafra U, Martin Martin LS, Carloni E, Padalino C et al (2006) 18-month observational study on efficacy of intraarticular hyaluronic acid (Hylan G-F 20) injections under ultrasound guidance in hip osteoarthritis. Reumatismo 58(1):39–49

    PubMed  Google Scholar 

  58. Berg P, Olsson U (2004) Intra-articular injection of non-animal stabilised hyaluronic acid (NASHA) for osteoarthritis of the hip: a pilot study. Clin Exp Rheumatol 22(3):300–306

    PubMed  CAS  Google Scholar 

  59. Qvistgaard E, Christensen R, Torp-Pedersen S, Bliddal H (2006) Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline. Osteoarthr Cartil 14(2):163–170

    Article  PubMed  CAS  Google Scholar 

  60. Conrozier T, Couris CM, Mathieu P, Merle-Vincent F, Piperno M, Coury F et al (2009) Safety, efficacy and predictive factors of efficacy of a single intra-articular injection of non-animal-stabilized-hyaluronic-acid in the hip joint: results of a standardized follow-up of patients treated for hip osteoarthritis in daily practice. Arch Orthop Trauma Surg 129(6):843–848

    Article  PubMed  Google Scholar 

  61. Richette P, Ravaud P, Conrozier T, Euller-Ziegler L, Mazieres B, Maugars Y et al (2009) Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. Arthr Rheum 60(3):824–830

    Article  CAS  Google Scholar 

  62. Moskowitz RW, Blaine TA (2005) An overview of treatment options for persistent shoulder pain. Am J Orthop 34(12 Suppl):10–15

    PubMed  Google Scholar 

  63. Silverstein E, Leger R, Shea KP (2007) The use of intra-articular hylan G-F 20 in the treatment of symptomatic osteoarthritis of the shoulder: a preliminary study. Am J Sports Med 35(6):979–985

    Article  PubMed  Google Scholar 

  64. Shibata Y, Midorikawa K, Emoto G, Naito M (2001) Clinical evaluation of sodium hyaluronate for the treatment of patients with rotator cuff tear. J Shoulder Elbow Surg 10(3):209–216

    Article  PubMed  CAS  Google Scholar 

  65. Blaine T, Moskowitz R, Udell J, Skyhar M, Levin R, Friedlander J et al (2008) Treatment of persistent shoulder pain with sodium hyaluronate: a randomized, controlled trial. A multicenter study. J Bone Joint Surg Am 90(5):970–979

    Article  PubMed  Google Scholar 

  66. Itokazu M, Matsunaga T (1995) Clinical evaluation of high-molecular-weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 17(5):946–955

    Article  PubMed  CAS  Google Scholar 

  67. Leardini G, Perbellini A, Franceschini M, Mattara L (1988) Intra-articular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther 10(5):521–526

    PubMed  CAS  Google Scholar 

  68. Calis M, Demir H, Ulker S, Kirnap M, Duygulu F, Calis HT (2006) Is intraarticular sodium hyaluronate injection an alternative treatment in patients with adhesive capsulitis? Rheumatol Int 26(6):536–540

    Article  PubMed  CAS  Google Scholar 

  69. Tamai K, Mashitori H, Ohno W, Hamada J, Sakai H, Saotome K (2004) Synovial response to intraarticular injections of hyaluronate in frozen shoulder: a quantitative assessment with dynamic magnetic resonance imaging. J Orthop Sci 9(3):230–234

    Article  PubMed  CAS  Google Scholar 

  70. Lee HJ, Lim KB, Kim DY, Lee KT (2009) Randomized controlled trial for efficacy of intra-articular injection for adhesive capsulitis: ultrasonography-guided versus blind technique. Arch Phys Med Rehabil 90(12):1997–2002

    Article  PubMed  Google Scholar 

  71. Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I (2008) Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol 26(2):288–294

    PubMed  CAS  Google Scholar 

  72. Cohen MM, Altman RD, Hollstrom R, Hollstrom C, Sun C, Gipson B (2008) Safety and efficacy of intra-articular sodium hyaluronate (Hyalgan) in a randomized, double-blind study for osteoarthritis of the ankle. Foot Ankle Int 29(7):657–663

    Article  PubMed  Google Scholar 

  73. Salk RS, Chang TJ, D’Costa WF, Soomekh DJ, Grogan KA (2006) Sodium hyaluronate in the treatment of osteoarthritis of the ankle: a controlled, randomized, double-blind pilot study. J Bone Joint Surg Am 88(2):295–302

    Article  PubMed  Google Scholar 

  74. Sun SF, Chou YJ, Hsu CW, Hwang CW, Hsu PT, Wang JL et al (2006) Efficacy of intra-articular hyaluronic acid in patients with osteoarthritis of the ankle: a prospective study. Osteoarthr Cartil 14(9):867–874

    Article  PubMed  Google Scholar 

  75. Filkova M, Senolt L, Braun M, Hulejova H, Pavelkova A, Sleglova O, et al. (2009) Serum hyaluronic acid as a potential marker with a predictive value for further radiographic progression of hand osteoarthritis. Osteoarthritis Cartilage

  76. Schumacher HR, Meador R, Sieck M, Mohammed Y (2004) Pilot Investigation of Hyaluronate Injections for First Metacarpal-Carpal (MC-C) Osteoarthritis. J Clin Rheumatol 10(2):59–62

    Article  PubMed  Google Scholar 

  77. Stahl S, Karsh-Zafrir I, Ratzon N, Rosenberg N (2005) Comparison of intraarticular injection of depot corticosteroid and hyaluronic acid for treatment of degenerative trapeziometacarpal joints. J Clin Rheumatol 11(6):299–302

    Article  PubMed  Google Scholar 

  78. Bahadir C, Onal B, Dayan VY, Gurer N (2009) Comparison of therapeutic effects of sodium hyaluronate and corticosteroid injections on trapeziometacarpal joint osteoarthritis. Clin Rheumatol 28(5):529–533

    Article  PubMed  Google Scholar 

  79. Fuchs S, Monikes R, Wohlmeiner A, Heyse T (2006) Intra-articular hyaluronic acid compared with corticoid injections for the treatment of rhizarthrosis. Osteoarthr Cartil 14(1):82–88

    Article  PubMed  CAS  Google Scholar 

  80. van Brakel RW, Eygendaal D (2006) Intra-articular injection of hyaluronic acid is not effective for the treatment of post-traumatic osteoarthritis of the elbow. Arthroscopy 22(11):1199–1203

    Article  PubMed  Google Scholar 

  81. Bjornland T, Gjaerum AA, Moystad A (2007) Osteoarthritis of the temporomandibular joint: an evaluation of the effects and complications of corticosteroid injection compared with injection with sodium hyaluronate. J Oral Rehabil 34(8):583–589

    Article  PubMed  CAS  Google Scholar 

  82. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M (2005) Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 172(8):1039–1043

    PubMed  Google Scholar 

  83. Divine JG, Zazulak BT, Hewett TE (2007) Viscosupplementation for knee osteoarthritis: a systematic review. Clin Orthop Relat Res 455:113–122

    Article  PubMed  Google Scholar 

  84. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 86-A(3):538–545

    PubMed  Google Scholar 

  85. Modawal A, Ferrer M, Choi HK, Castle JA (2005) Hyaluronic acid injections relieve knee pain. J Fam Pract 54(9):758–767

    PubMed  Google Scholar 

  86. Bellamy N (2006) Hyaluronic acid and knee osteoarthritis. J Fam Pract 55(11):967–968

    PubMed  Google Scholar 

  87. Salini V, De Amicis D, Abate M, Natale MA, Di Iorio A (2009) Ultrasound-guided hyaluronic acid injection in carpometacarpal osteoarthritis: short-term results. Int J Immunopathol Pharmacol 22(2):455–460

    PubMed  CAS  Google Scholar 

  88. Clerc D (2006) Sinovial® dans la gonarthrose: une étude en situation réelle d’utilisation chez 408 patients. Rhumatos 3(Suppl. 1):1–4

    Google Scholar 

  89. Pavelka K (2010) Efficacy evaluation of a highly purified intra-articular hyaluronic acid obtained by bacterial fermentation vs. hylan G-F20 in the treatment of symptomatic knee osteoarthritis: a double-blind, controlled, randomized, parallel-group non-inferiority study [abstract]. Osteoporos Int 21(Suppl 1):S387

    Google Scholar 

  90. Wei N, Delauter SK, Sheila JB (2002) Arthroscopic debridement and visco-supplementation: a minimally invasive treatment for symptomatic osteoarthritis involving the base of the thumb. J Clin Rheumatol 8(3):125–129

    Article  PubMed  Google Scholar 

  91. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K et al (1996) Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55(7):424–431

    Article  PubMed  CAS  Google Scholar 

  92. Puhl W, Bernau A, Greiling H, Kopcke W, Pforringer W, Steck KJ et al (1993) Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthr Cartil 1(4):233–241

    Article  PubMed  CAS  Google Scholar 

  93. Wu JJ, Shih LY, Hsu HC, Chen TH (1997) The double-blind test of sodium hyaluronate (ARTZ) on osteoarthritis knee. Zhonghua Yi Xue Za Zhi (Taipei) 59(2):99–106

    CAS  Google Scholar 

Download references

Acknowledgments

We thank Nila Bhana of inScience Communications, a Wolters Kluwer business, who provided medical writing support funded by IBSA. The authors have no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Gigante.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00296-011-1919-6

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gigante, A., Callegari, L. The role of intra-articular hyaluronan (Sinovial®) in the treatment of osteoarthritis. Rheumatol Int 31, 427–444 (2011). https://doi.org/10.1007/s00296-010-1660-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-010-1660-6

Keywords

Navigation